Urethra Carcinoma clinical trials at UC Health
1 research study open to new patients
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
open to eligible people ages 18 years and up
The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.
at UCLA UCSD
Last updated: